ferric ferrocyanide has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belik, AA; Hsieh, HY; Liao, YT; Liu, CH; Malgras, V; Wu, KC; Yamauchi, Y; Zakaria, MB | 1 |
| Hu, M; Lian, HY; Liu, CH; Wu, KC; Yamauchi, Y | 1 |
2 other study(ies) available for ferric ferrocyanide and Bladder Cancer
| Article | Year |
|---|---|
Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Carriers; Drug Delivery Systems; Ferric Compounds; Ferrocyanides; Humans; Magnetics; Magnetite Nanoparticles; Porosity; Urinary Bladder; Urinary Bladder Neoplasms | 2015 |
Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery.
Topics: Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Cisplatin; Drug Carriers; Ferrocyanides; Humans; Nanoparticles; Polymers; Urinary Bladder Neoplasms | 2012 |